Error: Could not add to watchlist. X
+ Watchlist

GenVec Inc

GVC2:GR
Ticker Delisted
6.33
EUR
As of 2:08 AM EDT 6/19/2017
Volume
0
52Wk Range
2.17 - 8.43
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
52Wk Range
2.17 - 8.43
YTD Return
103.37%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
14.394
Shares Outstanding (m)
2.274
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.16%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
GenVec Inc. is a clinical-stage biopharmaceutical focused on leveraging its proprietary adenovector gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines. The Company's lead product is involved in studies involving hearing loss and balance disorders. GenVec also focuses on licensing opportunities of its proprietary vectors and production cell lines.
Address
910 Clopper Road
Suite 220N
Gaithersburg, MD 20878
United States
Phone
1-240-632-0740
  • Douglas J Swirsky
    President/CEO/Secretary
  • Douglas E Brough
    Chief Scientific Officer
  • Bryan T Butman
    Senior VP:Development
  • James V Lambert
    Senior Dir:Acctg & Finance/Treasurer
  • Rena Cohen
    Investor Relations
Show More